Skip to main content
Clinical Trials/CTRI/2025/08/093576
CTRI/2025/08/093576
Not yet recruiting
Phase 2

Clinical evaluation of implant stability and crestal bone loss using osseodensification technique - A randomised control trial.

Dr Nandini Metaliya1 site in 1 country24 target enrollmentStarted: September 5, 2025Last updated:

Overview

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Dr Nandini Metaliya
Enrollment
24
Locations
1
Primary Endpoint
Primary implant stability

Overview

Brief Summary

The comparison of implant stability outcomes between conventional and osseodensification techniques is essential to understand their respective impacts on the quality and quantity of bone followed by amount of osseointegration after implant placement. This study aims to assess whether osseodensification provides superior bone density compared to conventional techniques, potentially leading to improved clinical outcomes, such as better initial implant stability ,lesser loss of crestal bone, improved insertion torque, reduced healing times, and long-term success rates. Investigating these techniques could also help in refining implant protocols, particularly for patients with compromised bone quality, and guide clinicians in selecting most appropriate method for various clinical scenarios.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant and Outcome Assessor Blinded

Eligibility Criteria

Ages
21.00 Year(s) to 50.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • 1.Patients exhibiting either partial edentulous ridges in maxilla or mandible.
  • Patients in age group of
  • 50 years of either sex, being systemically healthy with diabetes and /or hypertension under control opting for dental implants as a treatment option.
  • Patients with adequate ridge height.
  • Patient ready to give written informed consent.
  • Patients with D2,D3 and D4 density of maxillary and/or mandibular alveolar bone type.

Exclusion Criteria

  • 1.Medically compromised patients, which contraindicates the surgery, immune compromised patients.
  • 2.Smokers and smokeless tobacco users.
  • Patients not willing for implant prosthesis.

Outcomes

Primary Outcomes

Primary implant stability

Time Frame: baseline | 3 months | 6 months

Secondary implant stability

Time Frame: baseline | 3 months | 6 months

Crestal bone loss

Time Frame: baseline | 3 months | 6 months

Secondary Outcomes

  • Insertion torque value

Investigators

Sponsor
Dr Nandini Metaliya
Sponsor Class
Other [self sponsered]
Responsible Party
Principal Investigator
Principal Investigator

Nandini Metaliya

GDC&H Mumbai

Study Sites (1)

Loading locations...

Similar Trials